Emeren Group Announces Completion of Merger
NORWALK, Conn., Dec. 15, 2025 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced the completion of the merger contemplated by the...
What's New in Helsinki 2026: Architecture, Design, Wellness and Culture
HELSINKI, Dec. 15, 2025 /PRNewswire/ -- In 2026, Helsinki invites international visitors to experience a city where design icons, Nordic wellbeing, and a dynamic food and culture scene come together. From major Alvar Aalto milestones and renewed...
ATTACK SHARK Unveils V8: A Next-Generation Lightweight Wireless Gaming Mouse Built for Competitive Dominance
NEW YORK, Dec. 15, 2025 /PRNewswire/ -- On December 15, ATTACK SHARK, a gaming peripheral brand specializing in affordable, high-performance mechanical keyboards, gaming mice, and accessories, released the V8, a next-generation lightweight wireless...
DIFC becomes top five global hub for hedge fund managers - over 100 hedge funds now registered in the Centre
DUBAI, UAE, Dec. 15, 2025 /PRNewswire/ -- DIFC, the leading global financial centre in the Middle East, Africa and South Asia region, has registered its 100th hedge fund, reflecting its dominance in the sector and successful journey to becoming a...
Beko reaches its seventh consecutive year with the highest S&P Global Corporate Sustainability Assessment score in the DHP Household Durables Industry
ISTANBUL, Dec. 15, 2025 /PRNewswire/ -- Beko**, a global leader in home appliances, has secured a score of 86/100 in the 2025 S&P Global Corporate Sustainability Assessment (CSA), based on the evaluation dated 16 October 2025. The company's...
OLLOBOT to Make Its Debut at CES 2026
LAS VEGAS, Dec. 15, 2025 /PRNewswire/ -- OLLOBOT, a brand focused on fusing advanced technology with emotional companionship, will make its first appearance at CES 2026 (January 6–9). At Booth 53571 in Halls A-D of the Las Vegas Convention Center,...
Minghui Pharmaceutical Announces FDA clearance of IND to Initiate Global Phase Ⅲ Trials of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Thyroid Eye Disease
SHANGHAI and HANGZHOU, China, Dec. 15, 2025 /PRNewswire/ -- Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announced the U.S. Food and Drug...
iCHASE Introduces the World's First AI-Powered Bird Deterrent With Full Data Tracking at IPPE 2026
ATLANTA, Dec. 15, 2025 /PRNewswire/ -- iCHASE, a global leader in AI-driven agricultural biosecurity solutions, will showcase the world's first AI-powered bird deterrent system with full data tracking capabilities at the 2026 International...